“In silico study of the pharmacological, toxicological activities of the secondary compounds of Zingiber officinale Roscoe and analysis of their possible interactions with targets of the inflammatory process” (2024) Health and Biosciences, 5(2), pp. 5–30. doi:10.47456/hb.v5i2.44631.